Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Convertible Debt (2016 - 2017)

STRATA Skin Sciences' Convertible Debt history spans 4 years, with the latest figure at $13.4 million for Q2 2017.

  • For Q2 2017, Convertible Debt rose 23.67% year-over-year to $13.4 million; the TTM value through Jun 2017 reached $13.4 million, up 23.67%, while the annual FY2016 figure was $12.0 million, N/A changed from the prior year.
  • Convertible Debt for Q2 2017 was $13.4 million at STRATA Skin Sciences, up from $12.7 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $13.4 million in Q2 2017 and bottomed at $5.0 million in Q4 2014.
  • The 4-year median for Convertible Debt is $11.1 million (2015), against an average of $10.2 million.
  • The largest annual shift saw Convertible Debt soared 125.99% in 2015 before it rose 0.22% in 2016.
  • A 4-year view of Convertible Debt shows it stood at $5.0 million in 2014, then surged by 127.41% to $11.4 million in 2015, then grew by 5.76% to $12.0 million in 2016, then rose by 11.29% to $13.4 million in 2017.
  • Per Business Quant, the three most recent readings for SSKN's Convertible Debt are $13.4 million (Q2 2017), $12.7 million (Q1 2017), and $12.0 million (Q4 2016).